Jeff Cheng is an associate in the firm's Business Law Department and a member of its Technology Companies Group. Mr. Cheng joined Goodwin in 2010.

Prior to joining Goodwin, Mr. Cheng was an associate in the Silicon Valley office of Gunderson Dettmer LLP.

Mr. Cheng’s past and current representative venture capital clients include Accel Partners, Andreessen Horowitz, Battery Ventures, Benchmark Capital, Greylock Partners, Index Ventures, Khosla Ventures, Kleiner Perkins Caufield & Byers, Mayfield Fund, Redpoint Ventures and Sequoia Capital. His past and current representative company clients include Dropcam, Eventbrite, Guidewire Software, Hortonworks, Imperva, Infoblox, Marketo, The 41st Parameter, Topsy Labs, Twilio and Zendesk.

Mr. Cheng’s transactional experience includes the following representations:

  • Spinifex Pharmaceuticals, in its sale to Novartis, for approximately $200 million in upfront consideration plus undisclosed clinical milestone payments
  •, in its sale to LinkedIn, for approximately $1.5 billion in a mix of cash and stock consideration
  • Twilio, in venture capital financings raising an aggregate of over $200 million
  • Dropcam, in its sale to Nest Labs, a subsidiary of Google, for approximately $555 million
  • Andreessen Horowitz, Matrix Partners and Spark Capital, in the sale of their portfolio company, Oculus VR, to Facebook for approximately $2 billion in cash and stock consideration
  • Greycroft Partners and Upfront Ventures, in the sale of their portfolio company, Maker Studios, to The Walt Disney Company for $500 million in cash and up to an additional $450 million in contingent consideration
  • Eventbrite, in venture capital financings raising an aggregate of approximately $200 million
  • Zendesk (NYSE: ZEN), in its initial public offering
  • Kleiner Perkins and other venture investors, in the sale of their portfolio company, Nest Labs, to Google for approximately $3.2 billion
  • Khosla Ventures, in the sale of its portfolio company, The Climate Corporation, to Monsanto for approximately $930 million
  • Topsy Labs, in its sale to Apple
  • The 41st Parameter, in its sale to Experian for approximately $325 million
  • Zendesk, in its $45 million Series D financing and tender offer by its venture investors of approximately $38 million from existing stockholders
  • Marketo, in its $50 million Series F financing
  • Guidewire Software (NYSE: GWRE), in its initial public offering
  • PEAK Surgical, in its sale to Medtronic for approximately $120 million
  • Imperva (NASDAQ: IMPV), in its initial public offering
  • BigFix, in its sale to IBM
Areas of Practice

In The News







J.D., 2006
University of California, Berkeley School of Law
B.A., Molecular & Cell Biology, 1997
University of California, Berkeley



Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers